Hims & Hers (HIMS) Director Granted 3,656 RSUs — 08/06/2025

Pendarvis Christiane, a director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs) on 08/06/2025.

Rhea-AI Filing Summary

Pendarvis Christiane, a director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs) on 08/06/2025. Each RSU represents a contingent right to receive one share of Class A common stock at no cash price, and the award is recorded as a direct ownership interest of 3,656 shares following the grant.

The RSUs vest subject to continuous service on the earlier of the company’s 2026 annual meeting of stockholders or June 15, 2026, meaning the award is intended to align the director’s incentives with shareholder outcomes over the coming year.

Insights

Financial Analyst

TL;DR Small, routine equity award to a director; immaterial to company valuation but aligns incentives.

The grant of 3,656 RSUs to a director is a non-cash compensation event that converts to one share per RSU upon vesting and shows standard retention-based pay design. Because the award size is modest and recorded as direct ownership, it is unlikely to materially affect share count or financial metrics. The vesting tied to continuous service and the 2026 annual meeting underscores a near-term retention objective rather than a strategic transaction.

Corporate Governance Expert

TL;DR Typical governance practice: equity grant with service-based vesting to align director interests with shareholders.

This Form 4 discloses a standard restricted stock unit grant to a director, exercisable into Class A common stock at no purchase price. Vesting conditioned on continuous service and the earlier of the 2026 annual meeting or June 15, 2026 reflects common governance practice to retain board members and align incentives. The filing shows direct beneficial ownership of 3,656 RSUs, with no indication of related-party arrangements or indirect holdings disclosed here.

Insider Trade Summary

Grant/Award: 3,656 shares

Grant/Award 1 txn

Insider Pendarvis Christiane

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	3,656	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 3,656 contracts (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did HIMS report involving Pendarvis Christiane?

Pendarvis Christiane was granted 3,656 Restricted Stock Units (RSUs) that convert to Class A common stock, recorded as direct ownership following the grant.

When was the RSU grant to the HIMS director executed?

The transaction date is 08/06/2025.

What are the vesting terms for the 3,656 RSUs in the HIMS Form 4?

The RSUs vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.

Does the Form 4 show direct or indirect ownership for the RSUs?

The filing reports the RSUs as direct ownership (D).

What price was paid for the RSUs granted to the HIMS director?

The RSUs carry a $0 price and represent a contingent right to receive one share per RSU upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pendarvis Christiane

(Last) (First) (Middle)

2269 CHESTNUT ST., #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/06/2025		A		3,656		(1)	(1)	Class A Common Stock	3,656	$0	3,656	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.